Why the study?
Does human atrial natriuretic peptide inhibit osmolality-induced arginine vasopressin release in normal volunteers?
Does human atrial natriuretic peptide inhibit osmolality-induced arginine vasopressin release in normal volunteers?
Atrial natriuretic peptide inhibits osmolality-induced arginine vasopressin release in humans, highlighting its physiological role in volume and osmolality regulation.
No takes yet. Share an insight, caveat, or question.
Confirms ANP inhibits AVP release in humans; strengthens physiological model of volume homeostasis and opens research into cardiorenal interactions.
Allen et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: